Abstract:Although paclitaxel (PTX) is a first‑line chemotherapeutic agent for the treatment of epithelial ovarian cancer (EOC), its clinical use is restricted by chemoresistance. Autophagy is believed to promote drug resistance, and WW domain‑containing oxidoreductase (WWOX) has been predicted to serve an essential role in apoptosis induction and to suppress autophagy in various tumor cell types. In the present study, the role of WWOX was demonstrated using PTX‑treated EOC cells. Cell viability and apoptosis were detected using Cell Counting Kit‑8, morphological and flow cytometric analyses. WWOX and phosphorylated (p)‑WWOX were highly expressed in PTX‑treated sensitive EOC cells (A2780), which was accompanied by activation of the apoptosis‑related proteins caspase‑3 and poly (ADP‑ribose) polymerase (PARP). Conversely, PTX‑resistant EOC cells (A2780/T) were characterized by reduced WWOX expression and constant phosphorylation levels, as well as undetectable levels of activated caspase‑3 and PARP when cells were treated with PTX. The altered expression of WWOX between the two cell types was further validated by reverse transcription‑-quantitative PCR. The apoptosis‑inducing role of WWOX was also confirmed by flow cytometry after WWOX overexpression was induced in PTX‑treated A2780 cells. These findings indicated that WWOX activation may inhibit chemoresistance and trigger cancer cell death. The upregulated expression levels of the autophagy‑related protein 12‑5 complex, Beclin‑1 and LC3, as well as the downregulation of P62, were also detected following PTX treatment, suggesting that PTX induced autophagic flux in both types of EOC cells. This conclusion was further supported by visualizing the accumulation of autophagosome and autolysosome vesicles, using confocal microscopy and transmission electron microscopy. PTX was also shown to inhibit mTOR signaling, indicated by a decreased level of p‑mTOR and increased expression of eukaryotic translation initiation factor 4E‑binding protein 1. Finally, the interaction between WWOX, mTOR and autophagy was investigated via WWOX transfection experimentation, and indicated that WWOX activated mTOR whilst inhibiting autophagy. These data indicated that WWOX may serve a critical role in PTX‑induced apoptosis and could suppress autophagy by downregulating essential autophagic effectors in EOC cells via mTOR signaling.

WWOX Suppresses Cell Growth and Induces Cell Apoptosis Via Inhibition of P38 Nuclear Translocation in Cholangiocarcinoma

[Expression of WW Domain Containing Oxidoreductase Gene in Cholangiocarcinoma and Its Effect on the Biological Behavior of Cancer Cell Line RBE].

Association of Downregulation of WWOX with Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Curative Resection.

Expression of WW domain-containing oxidoreductase gene in patients with extrahepatic cholangiocarcinoma

Loss of WWOX expression in human extrahepatic cholangiocarcinoma

Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell in Vitro and in Vivo

WWOX Tuning of Oleic Acid Signaling Orchestrates Immunosuppressive Macrophage Polarization and Sensitizes Hepatocellular Carcinoma to Immunotherapy

Low Expression of WW Domain‐containing Oxidoreductase Associates with Hepatocellular Carcinoma Aggressiveness and Recurrence after Curative Resection

Inhibition of WWP 2 Suppresses Proliferation , and Induces G 1 Cell Cycle Arrest and Apoptosis in Liver Cancer Cells

LncRNA WWOX-AS1 Sponges Mir-20B-5p in Hepatocellular Carcinoma and Represses Its Progression by Upregulating WWOX

Molecular Mechanism of WWOX Inhibiting the Development of Esophageal Cancer by Inhibiting Hippo Signaling Pathway

Expression of WWOX in Hepatocellular Carcinoma and Resection Margin

WWOX-mediated Apoptosis in A549 Cells Mainly Involves the Mitochondrial Pathway.

Knockdown of Wwp1 Inhibits Growth and Induces Apoptosis in Hepatoma Carcinoma Cells Through the Activation of Caspase3 and P53

WWOX Activation by Toosendanin Suppresses Hepatocellular Carcinoma Metastasis Through JAK2/Stat3 and Wnt/-catenin Signaling

Relationship between promoter methylation status and protein expression of the wwox gene in hepatocellular carcinoma

Expression of FOXP1 and FOXO3a in extrahepatic cholangiocarcinoma and the implications in clinicopathological significance and prognosis.

OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis

WWOX promotes apoptosis and inhibits autophagy in paclitaxel‐treated ovarian carcinoma cells

WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signaling.

ACK1 Promotes Hepatocellular Carcinoma Progression Via Downregulating WWOX and Activating AKT Signaling